Library Logo

HPLC methods for clinical pharmaceutical analysis : (Record no. 34801)

000 -LEADER
fixed length control field 03587cam a22003977a 4500
001 - CONTROL NUMBER
control field 17278804
003 - CONTROL NUMBER IDENTIFIER
control field BD-DhUL
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20150121172301.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 120430s2012 gw a b 001 0 eng d
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2012392592
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER
Record control number 015904442
Source Uk
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783527331291
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)ocn753624304
040 ## - CATALOGING SOURCE
Original cataloging agency BTCTA
Language of cataloging eng
Transcribing agency BTCTA
Modifying agency BD-DhUL
-- BD-DhUL
042 ## - AUTHENTICATION CODE
Authentication code lccopycat
050 00 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RS189
Item number .M36 2012
072 #7 - SUBJECT CATEGORY CODE
Subject category code R
Source lcco
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.1901
Item number MAH
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Mascher, Hermann.
245 10 - TITLE STATEMENT
Title HPLC methods for clinical pharmaceutical analysis :
Remainder of title a user's guide /
Statement of responsibility, etc. Hermann Mascher.
250 ## - EDITION STATEMENT
Edition statement 1st ed.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. Weinheim :
Name of publisher, distributor, etc. Wiley-VCH,
Date of publication, distribution, etc. c2012.
300 ## - PHYSICAL DESCRIPTION
Extent ix, 247 p. :
Other physical details ill. ;
Dimensions 25 cm.
365 ## - TRADE PRICE
Price type code US$
Price amount 81.95
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note 1.Introduction -- 1.1.First Question: Determination of Ibuprofen in Plasma -- 1.2.Second Question: Determination of Tryptophan in Urine -- 1.3.Third Question: Determination of Paclitaxel in Tissue -- 2.Planning of Analyses -- 2.1.Introduction -- 2.2.Limit of Detection (LOD) and Determination (LLOQ) -- 2.3.Detectors -- 2.4.Structure of the Analyte -- 2.5.Solubility of an Analyte -- 2.6.Selection of the Detector -- 3.Sample Preparation -- 3.1.Dilution -- 3.2.Protein Precipitation, Overview -- 3.3.Extraction -- 4.HPLC Separation -- 4.1.HPLC Pumps -- 4.2.Degasser -- 4.3.Injector -- 4.4.HPLC Columns -- 5.Detection -- 5.1.Detection in the Pharmaceutical/Bioanalytical Area -- 5.2.Detection in the "Clinical Area" (Therapy Control/Compliance) -- 6.Chemical Derivatization for Detection Enhancement -- 7.Validation Concepts -- 7.1.Introduction -- 7.2.Realization of the FDA Guideline -- 8.Practical Hints Concerning Stability, Destruction and Degradation Products -- 9.Metabolites -- 10.Internal Standards -- 11.Case Studies with Intensive Discussion for Each Substance -- 11.1.Acetylcarnitine in Plasma -- 11.2.Acetylcysteine in Plasma -- 11.3.Acyclovir in Plasma and Urine -- 11.4.Caffeine in Plasma -- 11.5.Diazepam in Plasma -- 11.6.Diclofenac in Plasma -- 11.7.Dihydralazine in Plasma -- 11.8.Duramycin (Moli1901) in Plasma -- 11.9.Fluticasone Propionate in Plasma -- 11.10.Hydroxytriamterene Sulfate and Triamterene in Plasma and Urine -- 11.11.Ibuprofen in Plasma (also Enantiomeric Separation) -- 11.12.Minocycline in Plasma -- 11.13.Norfloxacine in Plasma and Urine -- 11.14.Paclitaxel in Plasma, Urine and Tissue -- 11.15.Paracetamol (Acetaminophen) in Plasma -- 11.16.Pimelic Acid in Plasma and Urine -- 11.17.8-Prenylnaringenin in Plasma and Different Types of Tissues -- 11.18.Silibinin in Plasma -- 11.19.Valnemulin in Plasma, Different Tissue Types and in Animal Feed -- 11.20.Vitamin B1 (Total Thiamine) in Plasma -- Table 11.1 Recommended books -- Table 11.2 Properties of substances -- Appendix -- Short Description of Determination for about 100 Substances -- Substances listed in the Appendix.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element High performance liquid chromatography.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Analysis.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmaceutical technology.
856 42 - ELECTRONIC LOCATION AND ACCESS
Materials specified Contributor biographical information
Uniform Resource Identifier http://www.loc.gov/catdir/enhancements/fy1210/2012392592-b.html
856 42 - ELECTRONIC LOCATION AND ACCESS
Materials specified Publisher description
Uniform Resource Identifier http://www.loc.gov/catdir/enhancements/fy1210/2012392592-d.html
856 41 - ELECTRONIC LOCATION AND ACCESS
Materials specified Table of contents only
Uniform Resource Identifier http://www.loc.gov/catdir/enhancements/fy1210/2012392592-t.html
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN)
a 7
b cbc
c copycat
d 2
e ncip
f 20
g y-gencatlg
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Koha item type Books
Holdings
Price effective from Date last seen Permanent Location Not for loan Date acquired Source of classification or shelving scheme Koha item type Lost status Withdrawn status Copy number Source of acquisition Collection code Damaged status Shelving location Barcode Current Location Full call number
2015-01-212015-01-21Dhaka University Science Library 2014-05-05 Books  3PurchasedNon Fiction General Stacks481975Dhaka University Science Library615.1901 MAH
2015-01-212015-01-21Dhaka University Science Library 2014-05-05 Books  2PurchasedNon Fiction General Stacks481974Dhaka University Science Library615.1901 MAH
2015-01-212015-01-21Dhaka University Science Library 2014-05-05 Books  1PurchasedNon Fiction General Stacks481973Dhaka University Science Library615.1901 MAH
Last Updated on September 15, 2019
© Dhaka University Library. All Rights Reserved|Staff Login